Beta cell failure: Causes and consequences

International Journal of Clinical Practice, Supplement

Volumn , Issue 123, 2001, Pages 13-18

  Kahn, S E ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; INSULIN LISPRO; NATEGLINIDE;

CONFERENCE PAPER; DIABETES MELLITUS; HIGH RISK PATIENT; HUMAN; HYPERGLYCEMIA; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OVARY POLYCYSTIC DISEASE; PANCREAS ISLET BETA CELL; POSTPRANDIAL STATE; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL;

DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN; INSULIN RESISTANCE; ISLETS OF LANGERHANS; POSTPRANDIAL PERIOD;

EID: 33749211033     PISSN: 1368504X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. Assessing the potential for alpha-glucosidase inhibitors in prediabetic states
2. Beta cells in type II diabetes mellitus
3. Relationship between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests
4. Physiologic evaluation of factors controlling glucose tolerance in man: Measurement of insulin sensitivity and β-cell glucose sensitivity from the response to intravenous glucose
5. Regulation of B-cell function in vivo: From health to disease
6. The contribution of insulin dependent and independent glucose uptake to intravenous glucose tolerance in healthy human subjects
7. Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects
8. The glucose intolerance of ageing. Implications for intervention
9. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome
10. Insulin resistance and impaired insulin secretion in subjects with histories of gestational diabetes mellitus
11. Predictors of progression from impaired glucose tolerance to NIDDM: An analysis of six prospective studies
12. Obesity, body fat distribution, insulin sensitivity and islet beta-cell function as explanations for metabolic diversity
13. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus
14. Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development
15. The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects
16. Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans
17. Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus
18. Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance
19. Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance
20. Impaired postprandial glucose utilization in non-insul-independent diabetes mellitus
21. Impairment of early insulin response after glucose load, rather than insulin resistance, is responsible for postprandial hyperglycaemia seen in obese type 2 diabetes: Assessment using nateglinide, a new insulin secretagogue
22. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients
23. Regulation of insulin secretion in vivo